[HTML][HTML] Gut microbiome alterations in Alzheimer's disease
Alzheimer’s disease (AD) is the most common form of dementia. However, the etiopathogenesis
of this devastating disease is not fully understood. Recent studies in rodents suggest …
of this devastating disease is not fully understood. Recent studies in rodents suggest …
Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study
Objective Insulin resistance (impaired insulin action) has been associated with Alzheimer
disease (AD) and memory impairment, independent of AD. Peroxisome proliferator-activated …
disease (AD) and memory impairment, independent of AD. Peroxisome proliferator-activated …
Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial
MW Dysken, M Sano, S Asthana, JE Vertrees, M Pallaki… - Jama, 2014 - jamanetwork.com
Importance Although vitamin E and memantine have been shown to have beneficial effects
in moderately severe Alzheimer disease (AD), evidence is limited in mild to moderate AD. …
in moderately severe Alzheimer disease (AD), evidence is limited in mild to moderate AD. …
[HTML][HTML] Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS–cognitive and …
…, HN Hodis, F Naftolin, SM Harman, S Asthana - PLoS …, 2015 - journals.plos.org
Background Menopausal hormone therapy (MHT) reportedly increases the risk of cognitive
decline in women over age 65 y. It is unknown whether similar risks exist for recently …
decline in women over age 65 y. It is unknown whether similar risks exist for recently …
Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose
S Craft, S Asthana, JW Newcomer… - Archives of general …, 1999 - jamanetwork.com
Background Increasing plasma glucose levels improves memory in patients with Alzheimer
disease (AD). Increasing plasma glucose levels also increases endogenous insulin levels, …
disease (AD). Increasing plasma glucose levels also increases endogenous insulin levels, …
Association of insulin resistance with cerebral glucose uptake in late middle–aged adults at risk for Alzheimer disease
…, RL Koscik, EM Jonaitis, MA Sager, S Asthana - JAMA …, 2015 - jamanetwork.com
Importance Converging evidence suggests that Alzheimer disease (AD) involves insulin
signaling impairment. Patients with AD and individuals at risk for AD show reduced glucose …
signaling impairment. Patients with AD and individuals at risk for AD show reduced glucose …
Insulin dose–response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype
S Craft, S Asthana, DG Cook, LD Baker… - …, 2003 - Elsevier
In previous studies, adults with Alzheimer’s disease (AD) showed memory enhancement
when plasma insulin levels were raised to 85 μU/ml, whereas normal adults’ memory was …
when plasma insulin levels were raised to 85 μU/ml, whereas normal adults’ memory was …
[HTML][HTML] The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer's disease
…, SC Johnson, CM Carlsson, S Asthana… - Alzheimer's research & …, 2018 - Springer
Background Trimethylamine N-oxide (TMAO), a small molecule produced by the metaorganismal
metabolism of dietary choline, has been implicated in human disease pathogenesis, …
metabolism of dietary choline, has been implicated in human disease pathogenesis, …
Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer's disease
…, W Ashford, M Assaly, S Asthana… - Proceedings of the …, 2010 - National Acad Sciences
The ε4 allele of the apolipoprotein E (APOE) gene is the major genetic risk factor for
Alzheimer’s disease (AD), but limited work has suggested that APOE genotype may modulate …
Alzheimer’s disease (AD), but limited work has suggested that APOE genotype may modulate …
Hyperinsulinemia provokes synchronous increases in central inflammation and β-amyloid in normal adults
…, LD Baker, D Goldgaber, W Nie, S Asthana… - Archives of …, 2005 - jamanetwork.com
Background Inflammation has been implicated as a pathogenetic factor in Alzheimer disease,
possibly via effects on β-amyloid (Aβ). Hyperinsulinemia induces inflammation and is a …
possibly via effects on β-amyloid (Aβ). Hyperinsulinemia induces inflammation and is a …